256 related articles for article (PubMed ID: 34780576)
1. MK2a inhibitor CMPD1 abrogates chikungunya virus infection by modulating actin remodeling pathway.
Mamidi P; Nayak TK; Kumar A; Kumar S; Chatterjee S; De S; Datey A; Ghosh S; Keshry SS; Singh S; Laha E; Ray A; Chattopadhyay S; Chattopadhyay S
PLoS Pathog; 2021 Nov; 17(11):e1009667. PubMed ID: 34780576
[TBL] [Abstract][Full Text] [Related]
2. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
3. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
[TBL] [Abstract][Full Text] [Related]
4. DNA Damage Response Signaling Is Crucial for Effective Chikungunya Virus Replication.
Chatterjee S; Kumar S; Mamidi P; Datey A; Sengupta S; Mahish C; Laha E; De S; Keshry SS; Nayak TK; Ghosh S; Singh S; Subudhi BB; Chattopadhyay S; Chattopadhyay S
J Virol; 2022 Dec; 96(23):e0133422. PubMed ID: 36377875
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of stearylamine against chikungunya virus.
Jeengar MK; Kurakula M; Patil P; More A; Sistla R; Parashar D
Chem Phys Lipids; 2021 Mar; 235():105049. PubMed ID: 33422549
[TBL] [Abstract][Full Text] [Related]
6. 4'-Fluorouridine inhibits alphavirus replication and infection
Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
[TBL] [Abstract][Full Text] [Related]
7. P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages.
Nayak TK; Mamidi P; Sahoo SS; Kumar PS; Mahish C; Chatterjee S; Subudhi BB; Chattopadhyay S; Chattopadhyay S
Front Immunol; 2019; 10():786. PubMed ID: 31031770
[TBL] [Abstract][Full Text] [Related]
8. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.
Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
Issac TH; Tan EL; Chu JJ
J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 positively regulates Chikungunya virus replication by stabilizing viral non-structural protein nsP2 during infection.
Das I; Basantray I; Mamidi P; Nayak TK; B M P; Chattopadhyay S; Chattopadhyay S
PLoS One; 2014; 9(6):e100531. PubMed ID: 24959709
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of nobiletin against chikungunya virus in vitro.
Lin SC; Chen MC; Li S; Lin CC; Wang TT
Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan Restricts Chikungunya Virus Infection
De S; Mamidi P; Ghosh S; Keshry SS; Mahish C; Pani SS; Laha E; Ray A; Datey A; Chatterjee S; Singh S; Mukherjee T; Khamaru S; Chattopadhyay S; Subudhi BB; Chattopadhyay S
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0148921. PubMed ID: 34748384
[TBL] [Abstract][Full Text] [Related]
15. Tomatidine reduces Chikungunya virus progeny release by controlling viral protein expression.
Troost-Kind B; van Hemert MJ; van de Pol D; van der Ende-Metselaar H; Merits A; Borggrewe M; Rodenhuis-Zybert IA; Smit JM
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009916. PubMed ID: 34762680
[TBL] [Abstract][Full Text] [Related]
16. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
[TBL] [Abstract][Full Text] [Related]
17. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
[TBL] [Abstract][Full Text] [Related]
18. Antivirals against the Chikungunya Virus.
Battisti V; Urban E; Langer T
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372513
[TBL] [Abstract][Full Text] [Related]
19. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo studies reveal α-Mangostin, a xanthonoid from Garcinia mangostana, as a promising natural antiviral compound against chikungunya virus.
Patil P; Agrawal M; Almelkar S; Jeengar MK; More A; Alagarasu K; Kumar NV; Mainkar PS; Parashar D; Cherian S
Virol J; 2021 Feb; 18(1):47. PubMed ID: 33639977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
